Search

Bing Li

from Philadelphia, PA
Age ~45
Get Report
Also known as:
Li Bing
Related to:
Lian L Li, 64Wen Fei Li, 50Ying Li, 56Li Lian ChuLi Yun, 60Li Zhen, 61Jierong Li, 40Zhen M LiYun LiMei L Dai, 52Li Yun, 44Nai Liang Li, 62Liqun Li, 58Jiexin Li, 42L I SongC LianLi Z Song, 60Zhen D Li, 55Hongsheng Song, 55Qin B Liu, 51Li Hang, 44Li J Song, 56
Connected to:
Ai Q Li, 64Ai H Li, 81Aida Li, 67Aijun Li, 65Aiwen Q Li, 56Aiyan Li, 61Alan Li, 80Alice Li, 46Alida Li, 59Alisha Li, 31

Bing Li Phones & Addresses

  • Philadelphia, PA
  • Nashville, TN
  • 7145 Lynford St, Philadelphia, PA 19149

Work

Company: Balchem corporation Nov 2011 Position: Senior scientist

Education

School / High School: Drexel University Apr 2000 Specialities: Ph.D. in Materials Science and Engineering

Professional Records

Medicine Doctors

Bing Li Photo 1

Bing Li

View page
Specialties:
Anesthesiology
Education:
Beijing School Of Medicine (1989)

Resumes

Resumes

Bing Li Photo 2

Bing Li Middletown, NY

View page
Work:
Balchem Corporation

Nov 2011 to 2000
Senior Scientist
Honeywell International
Danbury, CT
Aug 2010 to Sep 2011
Research Scientist
Merck & Co., Inc
West Point, PA
Jun 2009 to Mar 2010
Sr. Research Chemist
Drexel University
Philadelphia, PA
Jul 2004 to Dec 2009
Research Fellow
Merck & Co., Inc
West Point, PA
Sep 2008 to Jun 2009
Research Chemist
Education:
Drexel University
Apr 2000 to 2009
Ph.D. in Materials Science and Engineering
Nanjing University
Apr 2000 to 2004
M.S. in Polymer Chemistry and Physics
Nanjing University
Apr 2000 to 2001
B.S. in Polymer Chemistry

Publications

Us Patents

Chiral Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex

View page
US Patent:
8076517, Dec 13, 2011
Filed:
May 29, 2008
Appl. No.:
12/155111
Inventors:
Robert Eugene Hormann - Melrose Park PA, US
Bing Li - Shrewsbury MA, US
Assignee:
Intrexon Corporation - Blacksburg VA
International Classification:
C07C 243/10
US Classification:
564310
Abstract:
The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements.

Injectable Dual Delivery Allograph Bone/Polymer Composite For Treatment Of Open Fractures

View page
US Patent:
20110236501, Sep 29, 2011
Filed:
Jan 12, 2011
Appl. No.:
13/005481
Inventors:
Scott A. Guelcher - Franklin TN, US
Bing Li - Troy NY, US
Andrea E. Hafeman - Los Angeles CA, US
Joseph C. Wenke - LaVernia TX, US
Kate V. Brown - Raolett, GB
International Classification:
A61K 35/32
A61P 19/00
A61P 35/00
A61P 31/00
A61K 31/7036
A61P 17/02
A61K 38/18
US Classification:
424549, 514 40, 514 82, 514 88
Abstract:
A biodegradable polyurethane scaffold, comprising at least one polyisocyante, polyisocyanate prepolymer, or both, at least one polyester polyol, at least one catalyst, wherein the density of said scaffold is from about 50 to about 250 kg m-3 and the porosity of the scaffold is greater than about 70 (vol %) and at least 50% of the pores are interconnected with another pore, and wherein the scaffold incorporates at least one biologically active component in powder form.

Chiral Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex

View page
US Patent:
20120116090, May 10, 2012
Filed:
Dec 6, 2011
Appl. No.:
13/312371
Inventors:
Robert Eugene HORMANN - Melrose Park PA, US
Bing Li - Shrewsbury MA, US
Assignee:
Intrexon Corporation - Blacksburg VA
International Classification:
C07C 243/38
C07D 213/56
C07D 333/38
C07D 307/68
C07D 317/68
C07D 319/18
US Classification:
546316, 564150, 564149, 549436, 549362, 549 72, 549487
Abstract:
The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements.

Encapsulated Cells And Composites Thereof

View page
US Patent:
20120183622, Jul 19, 2012
Filed:
Jan 18, 2012
Appl. No.:
13/353257
Inventors:
Scott A. Guelcher - Franklin TN, US
Baek-Hee Lee - Seoul, KR
Ruijing Guo - Xuzhou, CN
Bing Li - Troy NY, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 35/12
A61K 9/50
US Classification:
424497, 424 937
Abstract:
Embodiments of the present invention comprise biodegradable composites including a polyurethane component and cells encapsulated in gel beads, as well as methods of making such composite and uses thereof. In certain embodiments the gel beads are alginate beads. The composites may be moldable and/or injectable. After implantation or injection, a composition may be set to form a porous composite that provides mechanical strength, supports the in-growth of cells, and/or delivers cells to particular tissues. Inventive composites have the advantage of being able to fill irregularly shaped implantation sites, deliver cells in a localized and noninvasive manner, and optimize cell proliferation and differentiation of delivered cells.

Chiral Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex

View page
US Patent:
20120316066, Dec 13, 2012
Filed:
Dec 2, 2011
Appl. No.:
13/309918
Inventors:
Robert Eugene HORMANN - Melrose Park PA, US
Bing Li - Shrewsbury MA, US
Assignee:
Intrexon Corporation - Blacksburg VA
International Classification:
A61K 31/166
C07D 317/68
C07D 319/18
C07D 333/38
C07D 213/56
C07D 307/68
C12N 5/00
C12N 15/87
C12P 21/00
A61K 31/357
A61K 31/381
A61K 31/341
A61K 31/44
A61P 35/00
A01N 37/18
A01N 43/26
A01N 43/32
A01N 43/10
A01N 43/08
A01N 43/40
A01P 13/00
A01P 21/00
C07C 241/02
US Classification:
504260, 564310, 549436, 549362, 549 72, 546316, 549487, 435375, 435465, 435468, 435 691, 514615, 514466, 514452, 514448, 514471, 514355, 504335, 504296, 504293, 504289, 504299
Abstract:
The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements.

Isbn (Books And Publications)

Yin Hang Jian Guan Bian Jie Wen Ti Yan Jiu

View page
Author

Bing Li

ISBN #

7504937614

Hai Jun Ying Hao: Ren Min Hai Jun Ying Mo Hui Cui

View page
Author

Bing Li

ISBN #

7801517741

Control profile
Bing Li from Philadelphia, PA, age ~45 Get Report